Clinical Trial Update: Duloxetine vs Placebo in the Treatment of General Anxiety [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing duloxetine to placebo for generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anxiety | Phase 3 | Status: COMPLETED